Gila Therapeutics is at the forefront of developing a pioneering therapeutic platform aimed at treating obesity and cardiometabolic disorders through its innovative Topical Lingual Signaling technology. This approach utilizes an unexploited biological pathway to directly activate specific brain regions that regulate food intake and metabolism. By delivering natural peptide hormones noninvasively via a micro-dose that dissolves on the tongue, Gila's technology ensures that these hormones do not enter the bloodstream, thereby minimizing the risk of side effects. The rapid signaling to the brain is achieved through oral receptors, which stimulate the brain's satiety centers without affecting areas associated with nausea, a common issue with traditional systemic hormone therapies.

The company's unique method represents a significant advancement in the treatment of metabolic disorders, as it allows for targeted neural signaling without the systemic exposure that typically necessitates higher doses of hormones. Gila Therapeutics is the first company to leverage this tongue-brain connection for therapeutic purposes, making it a novel player in the biotech landscape. Their approach has been validated through extensive pre-clinical studies, which have shown no adverse effects in animal models, and successful Phase I trials, reinforcing the safety and efficacy of their technology. This innovative platform positions Gila Therapeutics to address the growing obesity epidemic and associated metabolic disorders effectively.

United States

Gila Therapeutics is a Boston-based clinical stage biotech company exploiting a novel, highly-targeted neural signaling system for the treatment of obesity, type 2 diabetes and associated metabolic disorders. Our innovative Topical Lingual Neural Signaling platform facilitates the direct activation of specific brain regions responsible for metabolic regulation through the delivery of natural peptide hormones without expectation of side effects. Our scientific advisory team is renowned globally for their unrivaled experience and pioneering contributions to the fields of endocrinology, neuroscience, and metabolic nephrology. Reach out to learn more about us.

Gila Therapeutics

Company Details